New drug BT-114143 passes first safety check in healthy volunteers
Knowledge-focused
Completed
This early-stage study tested a new drug called BT-114143 in 84 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitored for side effects and drug levels in the blood. The goal was not to trea…
Phase: PHASE1 • Sponsor: ScinnoHub Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC